Who We Are
In December 2013, the LSU Board of Supervisors and the Louisiana Board of Regents approved designation of the Center for Cardiovascular Diseases and Sciences (CCDS) here at LSU Health Sciences Center- Shreveport. The Malcolm Feist Cardiovascular Endowment now supports the CCDS with oversight from its Board of Directors to support and grow cardiovascular disease research and education through recruitment of new faculty, support of faculty research, major equipment purchases and, perhaps most important of all, funding of cardiovascular graduate and post-graduate training. With the enthusiastic support of Chancellor Barish, the Board of Directors, and the leadership of its Director, the CCDS is committed to supporting and expanding cardiovascular research and education. In the coming years, the CCDS will gain greater visibility on campus and national recognition for the exceptional cardiovascular research and training opportunities available here at LSU Health Sciences Center- Shreveport. Read the full CV Center Strategic Plan to learn more about the CV Center at LSUHSC-S.
Malcolm Feist Cardiovascular Endowment
Upon his death in February 1985, Malcolm Weiller Feist, a Shreveport attorney, donated his estate to the LSU Medical Center in Shreveport for the explicit purpose of supporting “research in cardiovascular diseases.” LSU Health Shreveport created an endowment from the estate. The interest revenue from this endowment, as well as gas and oil revenue from estate property, has been used to fund small research projects, shared major equipment and seed packages for faculty with research programs in the cardiovascular area. As the endowment has grown, some of the interest revenue has been applied toward larger cardiovascular-related projects, such as the creation of an endowed super-chair in medicine for diabetes research with matching funds provided by the Board of Regents. The substantial funds now generated from the Feist endowment provides the Institution with an opportunity to significantly expand cardiovascular research by investing in successful existing research programs and by developing new programs that complement existing strengths and facilitate the recruitment of clinical and basic science faculty with specializations in areas related to cardiovascular disease.